Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Palonosetron”

103 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 103 results

Not applicableStudy completedNCT00410488
What this trial is testing

Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)

Who this might be right for
SarcomaNauseaVomiting
M.D. Anderson Cancer Center 51
Large-scale testing (Phase 3)UnknownNCT03606369
What this trial is testing

Effectiveness and Quality of Life Analysis of Palonosetron Against Ondansetron Combined With Dexamethasone and Fosaprepitant in Prevention of Acute and Delayed Emesis Associated to Chemotherapy Moderate and Highly Emetogenic in Breast Cancer.

Who this might be right for
Breast NeoplasmAntineoplastic AgentsAntiemetics+1 more
Instituto Nacional de Cancerologia de Mexico 560
Not applicableStudy completedNCT02597907
What this trial is testing

Postoperative Nausea and Vomiting: Ramosetron Plus Aprepitant vs Palonosetron Plus Aprepitant

Who this might be right for
Postoperative Nausea and Vomiting
Kyungpook National University Hospital 88
Large-scale testing (Phase 3)UnknownNCT04912271
What this trial is testing

Granisetron Transdermal Patch for Prophylaxis of Delayed CINV

Who this might be right for
Chemotherapy-induced Nausea and Vomiting (CINV)
Fudan University 140
Not applicableStudy completedNCT01825733
What this trial is testing

Comparison of Palonosetron and Ramosetron for Preventing Patient-controlled Analgesia Related Nausea and Vomiting Following Spine Surgery

Who this might be right for
Postoperative Nausea and Vomiting
Yonsei University 196
Testing effectiveness (Phase 2)Study completedNCT00412425
What this trial is testing

Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 30
Not applicableStudy completedNCT01650961
What this trial is testing

The Effect of Palonosetron on the QTc Interval During Perioperative Period

Who this might be right for
Anesthesia, GeneralPalonosetron
Seoul National University Hospital 100
Post-approval studies (Phase 4)Study completedNCT02480088
What this trial is testing

Comparison of Palonosetron and Ramosetron for Preventing Patient-controlled Analgesia Related Nausea and Vomiting Following Spine Surgery; Association With ABCB1 Polymorphism

Who this might be right for
Postoperative Nausea and Vomiting
Yonsei University 300
Testing effectiveness (Phase 2)Study completedNCT04669132
What this trial is testing

Efficacy of Olanzapine, Netupitant and Palonosetron in Controlling Nausea and Vomiting Associated With Highly Emetogenic Chemotherapy in Patients With Breast Cancer

Who this might be right for
Nausea Post Chemotherapy
Instituto Brasileiro de Controle do Cancer 50
Testing effectiveness (Phase 2)Study completedNCT00306735
What this trial is testing

Safety and Efficacy Study for the Prevention of Nausea and Vomiting in Multiple Myeloma Patients Receiving Stem Cell Transplantation.

Who this might be right for
Multiple Myeloma
Eisai Inc. 75
Post-approval studies (Phase 4)Looking for participantsNCT06726291
What this trial is testing

Akynzeo as Antiemetic Treatment in Patients With Endometrial Cancer

Who this might be right for
Endometrial Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 84
Not applicableEnrolling By InvitationNCT07132749
What this trial is testing

NEPA in Patients With HER2-positive or HER2-low Advanced Breast Cancer Treated With T-DXd

Who this might be right for
Patients With HER2-positive Advanced Breast Cancer Treated With T-DXdPatients With HER2-low Advanced Breast Cancer Treated With T-DXd
Yeon Hee Park 100
Large-scale testing (Phase 3)Study completedNCT00359567
What this trial is testing

Comparative Study of Palonosetron With Granisetron as a Control in Patients Receiving Highly Emetogenic Chemotherapy

Who this might be right for
Chemotherapy-Induced Nausea and Vomiting
Taiho Pharmaceutical Co., Ltd. 1,140
Not applicableUnknownNCT03148704
What this trial is testing

Intensive Medicines Monitoring Project of Palonosetron Hydrochloride Capsules (Ruo Shan®)

Who this might be right for
Palonosetron
Cttq 3,000
Large-scale testing (Phase 3)Study completedNCT01074697
What this trial is testing

Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin

Who this might be right for
NauseaVomitingGenital Neoplasms, Female
Odense University Hospital 246
Post-approval studies (Phase 4)Study completedNCT06043336
What this trial is testing

Palonosetron vs Combination of Granisetron and Dexamethasone in Preventing PONV in Laparoscopic Cholecystectomy.

Who this might be right for
Postoperative Nausea and Vomiting
Universiti Kebangsaan Malaysia Medical Centre 134
Not applicableUnknownNCT02970643
What this trial is testing

Proof-of-Concept Trial of Palonosetron and Olanzapine Without Dexamethasone for the Prevention of CIN

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Hee Jun Kim 48
Not applicableStudy completedNCT00343863
What this trial is testing

Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer

Who this might be right for
Male Breast CancerNausea and VomitingStage I Breast Cancer+2 more
University of Washington 41
Post-approval studies (Phase 4)Not Yet RecruitingNCT07254416
What this trial is testing

A Study on Nausea and Vomiting Caused by T-DXd in Breast Cancer Patients

Who this might be right for
Breast Cancer Patients Treated With T-DXd
Tianjin Medical University Cancer Institute and Hospital 120
Large-scale testing (Phase 3)Study completedNCT03040726
What this trial is testing

Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With Cancer

Who this might be right for
Malignant NeoplasmNauseaVomiting
M.D. Anderson Cancer Center 53
Load More Results